The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis
Authors:
Open Access
- 9 April 2022
- journal article
- review article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 22 (1) , 1-13
Abstract
Introduction: The presence of inflammation is a key hallmark of cancer and, plays an important role in disease progression and survival in colorectal cancer (CRC). Calprotectin detected in the faeces is a sensitive measure of colonic inflammation. The role of FC as a diagnostic test that may categorise patients by risk of neoplasia is poorly defined. This systematic review and meta-analysis aims to characterise the relationship between elevations of FC and colorectal neoplasia.Methods: A systematic review was performed using the keywords (MESH terms) and a statistical and meta-analysis was performed.Results: A total of 35 studies are included in this review. CRC patients are more likely than controls to have an elevated FC OR 5.19, 95% CI 3.12–8.62,p < 0.001 with a heterogeneity (I2 = 27%). No tumour characteristics significantly correlated with FC, only stage of CRC shows signs that it may potentially correlate with FC.Conclusion: FC levels are significantly higher in CRC, with high sensitivity. Its low specificity prevents it from being used to diagnose or screen for CRC.Keywords
This publication has 55 references indexed in Scilit:
- Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary careScandinavian Journal of Gastroenterology, 2013
- A combination of faecal tests for the detection of colon cancerEuropean Journal of Gastroenterology & Hepatology, 2012
- Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational studyBMC Gastroenterology, 2012
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis, 2009
- Screening for colorectal cancer using the faecal occult blood test, HemoccultCochrane Database of Systematic Reviews, 2007
- Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT)Gut, 2004
- Faecal calprotectin levels in a high risk population for colorectal neoplasiaGut, 2000
- High prevalence of NSAID enteropathy as shown by a simple faecal testGut, 1999
- Assessment of Disease Activity in Ulcerative Colitis by Faecal Calprotectin, a Novel Granulocyte Marker ProteinDigestion, 1997
- Faecal Calprotectin: A Novel Test for the Diagnosis of Colorectal Cancer?Scandinavian Journal of Gastroenterology, 1993